MoneyWorks4Me

Alembic Pharmaceuticals informs about investor meeting

01 Jun 2023 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alembic Pharmaceuticals has informed that the management of the Company shall be meeting analysts/investors through Trinity India -2023 Annual Investor Conference hosted by Batlivala & Karani Securities India (‘B&K’) on 1st June, 2023.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..